|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Modified real-time PCR for detecting, differentiating, and quantifying Ureaplasma urealyticum and Ureaplasma parvum 显示文摘 | Vancutsem E Soetens O Breugelmans M | 2011 | J Mol Diagn2011，13，2： | 1 |
| 2 | Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line chemotherapy for advanced gastric cancer:a report of the V325 study group显示文摘 | VanCutsem E Moiseyenko VM Tjulandin S | | 0，，31： | 1 |
| 3 | Bevacizum-ab in combination with chemotherapy as first-line ther- apy in advanced gastric cancer: a randomized, double- blind,placebo-controlled phase 11I study 显示文摘 | Ohtsu A Shan M A Vancutsem E | 2011 | J Clin Oncol2011，29，30： | 1 |
| 4 | Effects of high frequency gastric stimulation on gastric slow waves,gastric emptying and symptoms in patients with gastroparesis显示文摘 | Tack J Coulie B Vancutsem E | 2000 | Gastroemterology2000，118，2： | 1 |
| 5 | Trastuzumab in combination with chemothempy versus chemotherapy alone for treatInent of HER2-positive advanced gastric or gastro-oesophagealagealjunction cancer(ToGA): A phase 3, open- label,randomised controlled trial显示文摘 | Bang Y J Vancutsem E Feyereislova A | 2010 | Lancet2010，376，： | 1 |
| 6 | A phase Ⅲ trial(SO14796) of Xeloda (capecitabine) in previously untreated advanced/metastatic colorectal cancer显示文摘 | Twelves C Harper P VanCutsem E | 1999 | Proc Am Soc Clin Oncol1999，18，： | 1 |
| 7 | Phase IIIstudyof docetaxel and cisplatin plus fluorouracil compared withcisplatinand fluorouracil as firstline therapy for advanced gastriccan cer:areport ofthe V325 study group显示文摘 | VanCutsem E Moiseyenko VM Tjulandin S et a1 | 2006 | J Clin Oncol2006，24，： | 1 |
| 8 | Phase 11 study of docetaxel and ciplatin plus fluorouracil compared with ciplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group显示文摘 | VanCutsem E Moiseyenko V M | 2002 | J Clin Oncol2002，20，8： | 1 |
| 9 | Modified realtime PCR for detecting,differentiating,and quantifying Ureaplasma urealyticum and Ureaplasma parvum显示文摘 | Vancutsem E Soetens O Breugelmans M | | 0，，02： | 1 |
| 10 | Production of recombinant antigens of ureaplasma parvum serotypes 3 and 6 for development of a serological assay 显示文摘 | VANCUTSEM E ECHAHIDI F VAN GEEL K | 2008 | Clin Vaccine Immunol2008，15，3： | 1 |
| 11 | Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as firstline therapy for advanced gastric cancer: A report of the V325 Study Group 显示文摘 | VanCutsem E Moiseyenko VM Tjulandin S | 2006 | J Clin Oncol2006，24，： | 1 |
| 12 | Mul-ticenterphase Ⅱ and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines显示文摘 | Lenzh J VanCutsem E Khambata FORD S | 2006 | J Clin Oncol2006，24，30： | 1 |
| 13 | Modified realtime PCR for detecting,differentiating,and quantifying Ureaplasma urealyticum and Ureaplasma parvum显示文摘 | Vancutsem E Soetens O Breugelmans M | 2011 | J Mol Diagn2011，13，2： | 1 |
| 14 | A phase III trial (S014796) of Xelcda (capecilabine) in previously untreated advanced/metastatic colorectal cancer 显示文摘 | Twelves C Harper P VanCutsem E | 1999 | Proc Am Soc Clin Oncol1999，18，： | 1 |
| 15 | Phase II1 trial of gemcitabine plus tipifarnib compared with gemcitabine plus place- bo in advanced pancreatic cancer显示文摘 | VanCutsem E van de Velde H Karasek P | 2004 | JClin Oncol2004，22，8： | 1 |
| 16 | The treatment of advanced gastric cancer : new find ings on the activity of the taxanes显示文摘 | VanCutsem E | 2004 | Oncologist2004，9，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员